C Raker
Overview
Explore the profile of C Raker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rojas K, Matthews N, Raker C, Clark M, Onstad M, Stuckey A, et al.
J Cancer Surviv
. 2017 Oct;
12(1):127-133.
PMID: 29043480
Purpose: We sought to explore the correlation between BMI and postoperative sexual function, body image, and breast-specific sensuality before and after breast cancer surgery. Methods: A cross-sectional survey of patients...
2.
Rojas K, Onstad M, Raker C, Clark M, Stuckey A, Gass J
Breast Cancer Res Treat
. 2017 Mar;
163(2):273-279.
PMID: 28260139
Background: As mastectomy rates increase and overall survival for early breast cancer improves, a better understanding of the long-term consequences of mastectomy is needed. We sought to explore the correlation...
3.
He M, Curran P, Raker C, Martin S, Larson L, Bourjeily G
Pathol Res Pract
. 2016 Feb;
212(4):282-7.
PMID: 26861722
Introduction: Obesity during pregnancy is associated with a wide spectrum of maternal, fetal and neonatal complications. This study compared placental pathology in women with obesity and normal weight gravidas. Materials...
4.
Allen R, Carey M, Raker C, Goyal V, Matteson K
J Obstet Gynaecol
. 2014 Feb;
34(3):263-7.
PMID: 24483244
The purpose of this prospective cohort study was to compare pain during IUD insertion between women with a history of vaginal delivery and women without a history of vaginal delivery....
5.
Mathews C, Restivo A, Raker C, Weitzen S, DiSilvestro P
Gynecol Oncol
. 2008 Oct;
112(1):161-5.
PMID: 18952272
Objectives: Fewer than 5% of cancer patients enroll in clinical trials, delaying their completion and the progress of patient care. Patients who are elderly or members of ethnic minorities participate...
6.
Browning Paul J, Wang E, Pettoello-Mantovani M, Raker C, Yurasov S, GOLDSTEIN M, et al.
AIDS Res Hum Retroviruses
. 2000 Apr;
16(5):481-92.
PMID: 10772534
To generate an in vivo system for investigating the postintegration phase of HIV-1 replication, mouse lines transgenic for a full-length infectious proviral clone of a monocyte-tropic HIV-1 isolate, HIV-1JR-CSF, were...
7.
Pettoello-Mantovani M, Kollmann T, Katopodis N, Raker C, Kim A, Yurasov S, et al.
J Infect Dis
. 1998 Feb;
177(2):337-46.
PMID: 9466519
Modified, human immunodeficiency virus (HIV)-inoculated thy/liv-SCID-hu mice were used to evaluate the in vivo efficacy of antiretroviral drugs. Ritonavir treatment alone initially suppressed plasma viremia, but the viremia recurred with...
8.
Browning J, Horner J, Pettoello-Mantovani M, Raker C, Yurasov S, DePinho R, et al.
Proc Natl Acad Sci U S A
. 1998 Feb;
94(26):14637-41.
PMID: 9405665
HIV entry into human cells is mediated by CD4 acting in concert with one of several members of the chemokine receptor superfamily. The resistance to HIV infection observed in individuals...
9.
Pettoello-Mantovani M, Kollmann T, Raker C, Kim A, Yurasov S, Tudor R, et al.
Antimicrob Agents Chemother
. 1997 Sep;
41(9):1880-7.
PMID: 9303378
Treatment with protease inhibitors alone or in combination with inhibitors of reverse transcriptase potently suppresses levels of human immunodeficiency virus (HIV) RNA in plasma and thereby may significantly delay the...